Milk–Based Formula Milk: Feihe Secures Official Approval to Enter Indonesian Market
Feihe, one of China’s leading infant nutrition brands, has reached a significant milestone in its international expansion strategy with the official approval of its “AceKid Activegro” formula series for entry into the Indonesian market. This development not only reinforces the company’s growing global footprint but also highlights its commitment to innovation in infant nutrition. Notably, the AceKid Activegro range is the first formula milk product in Indonesia to utilize fresh milk as its primary ingredient, setting a new benchmark in product formulation within the country.
Indonesia is known for maintaining some of the most rigorous regulatory standards for imported infant food products in Southeast Asia. Gaining approval in such a highly regulated market is widely regarded as a strong endorsement of a brand’s quality, safety, and compliance capabilities. For Feihe, this achievement underscores the company’s adherence to international standards and its ability to meet stringent requirements, further strengthening its credibility among global consumers and regulatory authorities alike.
The AceKid Activegro series stands out due to its proprietary “One-step Process,” an advanced manufacturing technique that transforms fresh milk directly into powdered formula in a single continuous process. This method minimizes the need for multiple processing stages, thereby helping to preserve the natural nutritional profile of the milk. By locking in essential nutrients more effectively, the process ensures that infants receive a product closer in composition to fresh milk, which is often considered the gold standard in early childhood nutrition.
Beyond its innovative production method, AceKid Activegro is formulated with a strong emphasis on natural nutrition. The product contains no added sucrose, maltodextrin, vanillin, or corn syrup—ingredients that are sometimes used in conventional infant formulas to enhance flavor or texture. By eliminating these additives, Feihe aims to promote healthier dietary habits from an early age. This approach is designed to help maintain stable blood sugar levels in infants, support optimal digestive function, and reduce the likelihood of developing a preference for overly sweet foods later in life.
The focus on clean-label nutrition also aligns with broader global trends, as parents increasingly seek transparent, minimally processed products for their children. By prioritizing purity and simplicity in its formulation, Feihe is positioning itself to meet the evolving expectations of modern consumers who value both safety and nutritional integrity.
Feihe’s expansion into Indonesia follows its successful entry into the Philippine market in 2025, where the company has rapidly scaled its presence to nearly 500 retail outlets. This steady growth across Southeast Asia reflects a carefully executed international strategy aimed at tapping into high-growth markets with rising demand for premium infant nutrition products. The company’s ability to adapt to diverse regulatory environments while maintaining consistent product quality has been a key driver of its overseas success.
In parallel with its commercial expansion, Feihe continues to invest heavily in scientific research and global collaboration. A recent example is the “Bridging Minds—2026 Advances in Neurodevelopment and Mental Health” summit held at the National University of Singapore. The event brought together leading experts from around the world to explore the latest advancements in brain nutrition and cognitive development, highlighting the critical role of early-life nutrition in shaping long-term health outcomes.
The summit was co-organized by the BCH-Feihe Pediatric Brain Development Initiative, the Neuroscience & Behavioural Disorders Programme at Duke-NUS Medical School, Boston Children’s Hospital, and Harvard Medical School. Through such collaborations, Feihe is actively contributing to cutting-edge research in pediatric health and nutrition, further strengthening its scientific foundation.
Feihe’s partnership with Harvard-affiliated institutions spans more than a decade, reflecting a long-term commitment to advancing knowledge in early childhood development. In 2023, this collaboration was formalized through the establishment of the BCH-Feihe Pediatric Brain Development Initiative, a research platform dedicated to studying the combined effects of genetics, nutrition, and environmental factors on brain development in infants and young children. The initiative aims to generate insights that can inform the next generation of nutritional products and interventions.
Today, Feihe has built an extensive global research network, collaborating with more than 40 research platforms across seven countries. This network enables the company to integrate diverse scientific perspectives and leverage cutting-edge technologies in its product development processes. By bridging academic research with industrial application, Feihe is working to translate scientific discoveries into tangible benefits for consumers.
In North America, Feihe has also made strategic investments to strengthen its manufacturing capabilities. The company established Canada’s first infant formula production facility, introducing China’s fully integrated dairy industry model to a developed market. This model emphasizes end-to-end control over the supply chain—from dairy farming to final product manufacturing—ensuring consistent quality, traceability, and efficiency.
According to Leng Youbin, Chairman of Feihe, the company is undergoing a significant transformation in its role within the global scientific community. “We are transitioning from a learner in global research to a participant, and even a definer,” he stated. This evolution reflects Feihe’s growing confidence and ambition as it seeks to shape the future of infant nutrition on a global scale.
Overall, the approval of AceKid Activegro in Indonesia represents more than just a market entry—it is a testament to Feihe’s innovation, quality standards, and commitment to scientific advancement. As the company continues to expand internationally and deepen its research collaborations, it is well positioned to play a leading role in the global infant nutrition industry, delivering products that combine cutting-edge science with a focus on natural, high-quality ingredients.
Source Link:https://www.businesswire.com/
